Psyence Biomedica…
USUSDPsyence Biomedical Ltd. (US:PBM) — Biotechnology: Pharmaceutical Preparations. Número de bolsas en las que cotizan las acciones de la empresa: 1. En esta página: cotización y gráfico, dividendos, principales accionistas e historial del número de acciones.
Sobre la Empresa
- Sitio Web
- psyencebiomed.com
- Sector
- Health Care · Biotechnology: Pharmaceutical Preparations
- Sede Central
- TORONTO, Canada
- Consejero Delegado
- Jody Aufrichtig
- Empleados
- 12
- Acciones en Circulación
- 2.29 M a 2026-03-31
- Capital Flotante
- 2.61 M
- Capitalización Bursátil
- 19.15 M USD
- Insiders
- 2.97%
- Inversores Institucionales
- 9.67%
- Industria (SIC)
- Pharmaceutical Preparations
- P/E
- pérdidas
- FCF
- −4.25 M USD
- Deuda
- 10.4 M USD
- Resultados y FCF — para los 12 meses hasta 30.09.2025 (el último informe de la empresa).
Descripción
Psyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in Phase IIb clinical study for the treatment of adjustment disorder in patients with cancer in a palliative care setting. The company is based in Toronto, Canada. Psyence Biomedical Ltd. is a subsidiary of Psyence Group Inc.
anuncio
Bolsas y Tickers
| Bolsa | Ticker | Moneda | Precio | Tipo |
|---|---|---|---|---|
| US USA Stocks | PBM | USD | 4.97 -2.93% | acciones ordinarias |
Principales Accionistas
| Titular | Participación | Acciones | Fecha del Informe |
|---|---|---|---|
| AdvisorShares Trust-Advi… | 4.61% | 175 687 | 2026-08-31 |
| Parallel Advisors, LLC | 3.97% | 151 250 | 2026-06-30 |
| AdvisorShares Investment… | 3.2% | 122 184 | 2026-06-30 |
| Morgan Stanley | 0.99% | 37 804 | 2026-06-30 |
| Jane Street Group, LLC | 0.8% | 30 431 | 2026-06-30 |
| Xtx Topco Ltd | 0.4% | 15 094 | 2026-06-30 |
| Citadel Advisors Llc | 0.31% | 11 693 | 2026-06-30 |
| UBS Group AG | 0% | 60 | 2026-06-30 |
| Caitlin John, LLC | 0% | 35 | 2026-06-30 |
